CLINICAL PHARMACOKINETICS OF THE SALICYLATES

被引：247

作者：

NEEDS, CJ ^{[1
]}

BROOKS, PM ^{[1
]}

机构：

[1] ROYAL N SHORE HOSP, DEPT RHEUMATOL, ST LEONARDS, NSW 2065, AUSTRALIA

来源：

CLINICAL PHARMACOKINETICS | 1985年 / 10卷 / 02期

关键词：

D O I：

10.2165/00003088-198510020-00004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：164 / 177

页数：14

相关论文

共 145 条

[1] ALI MA, 1969, CLIN CHEM, V15, P1027
[2] Anderson JAD, 1977, TXB ADVERSE DRUG REA, P217
[3] CLINICAL MEASUREMENT OF ANTI-INFLAMMATORY EFFECTS OF SALICYLATES IN RHEUMATOID ARTHRITIS
BOARDMAN, PL
HART, FD
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1967, 4 (5574): : 264 - +
[4] SALICYLATE METABOLITE KINETICS AFTER SEVERAL SALICYLATES
BOCHNER, F
GRAHAM, GG
CHAM, BE
IMHOFF, DM
HAAVISTO, TM
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 266 - 275
[5] KINETICS OF ELIMINATION OF SALICYLIC ACID AND FORMATION OF GENTISIC ACID
BOREHAM, DR
MARTIN, BK
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1969, 37 (01) : 294 - &
[6] BORGA O, 1976, CLIN PHARMACOL THER, V20, P464
[7] BIOAVAILABILITY OF ACETYLSALICYLIC-ACID AND SALICYLIC-ACID FROM RAPID-RELEASE AND SLOW-RELEASE FORMULATIONS, AND IN COMBINATION WITH DIPYRIDAMOL
BRANTMARK, B
WAHLINBOLL, E
MELANDER, A
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) : 309 - 314
[8] BRODIE BB, 1960, J PHARMACOL EXP THER, V130, P20
[9] FLURBIPROFEN-ASPIRIN INTERACTION - DOUBLE-BLIND CROSSOVER STUDY
BROOKS, PM
KHONG, TK
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 1977, 5 (01) : 53 - 57
[10] BROOKS PM, 1978, BRIT J CLIN PHARMACO, V5, P337, DOI 10.1111/j.1365-2125.1978.tb01717.x

← 1 2 3 4 5 6 7 8 9 10 →